| PTHRP, PTHrP | parathyroid-hormone-related peptide; parathyroid-hormone-related protein |
|---|---|
| RH | radiant heat; radiation hybrid; radiological health; reactive hyperemia; recurrent herpes; regulator... |
| SH | Salter-Harris [fracture]; Schonlein-Henoch [purpura]; self-help; serum hepatitis; sexual harassment;... |
| TSH-RH | thyroid-stimulating hormone-releasing hormone |
| ECT(?) | Electro-Convulsive Therapy; 전기 경련 요법 = EST |
| pregnancy hormone | <biochemistry, gynaecology> Produced in the corpus luteum, as an antagonist of oestrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development. (18 Nov 1997) |
|---|---|
| cytoreductive therapy | Therapy with the intention of reducing the number of cells in a lesion, usually a malignancy. (05 Mar 2000) |
| heart hormone | A substance present in extracts of cardiac tissue that augments cardiac contraction; possibly adenosine, a catecholamine, or some non-specific stimulant present generally in tissues. Synonym: cardiac hormone, heart hormone. (05 Mar 2000) |
| salivary gland hormone | <chemical> Chemical name: Parotin (12 Dec 1998) |
| salvage therapy | <oncology> The final possible treatment for people who are nonresponsive to or cannot tolerate other available treatments for a particular condition. (14 Oct 1997) |
| progestational hormone | <biochemistry, gynaecology> Produced in the corpus luteum, as an antagonist of oestrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development. (18 Nov 1997) |
| prolactin-inhibiting hormone | A substance of hypothalamic origin capable of inhibiting the synthesis and release of prolactin. Synonym: prolactin-inhibiting factor, prolactin-inhibiting hormone. Origin: prolactin + G. Stasis, standing still, + -in (05 Mar 2000) |
| prolactin release-inhibiting hormone | <chemical> A polypeptide hormone produced in the hypothalamus that inhibits the release of prolactin. Chemical name: Prolactin release-inhibiting factor (12 Dec 1998) |
| prolactin-releasing hormone | A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland. (12 Dec 1998) |
| proliferation therapy | Rehabilitation of an incompetent structure (ligament or tendon) by the induced proliferation of new cells; accomplished by injecting an irritating substance into the loose ligament or tendon, the resulting scar formation and contracture serving to tighten up the ligament or tendon as scar tissue proliferates. (05 Mar 2000) |
| proparathyroid hormone | The immediate precursor of parathyroid hormone; proparathyroid differs from parathyroid hormone by an N-terminal hexapeptide extension. (05 Mar 2000) |
| protein shock therapy | The injection of a foreign protein to induce fever as a means of treating certain diseases. Synonym: foreign protein therapy. (05 Mar 2000) |
| herz hormone | A substance present in extracts of cardiac tissue that augments cardiac contraction; possibly adenosine, a catecholamine, or some non-specific stimulant present generally in tissues. Synonym: cardiac hormone, heart hormone. (05 Mar 2000) |
| heterovaccine therapy | Therapy with a vaccine obtained from organisms not directly concerned with the disorder being treated. (05 Mar 2000) |
| sclerosing therapy | A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver. (27 Sep 1997) |